Decapeptyl SR 3mg Vial Triptorelin POM x1

Decapeptyl 3mg Injection

Powder for suspension for injection, sustained release formulation.

Therapeutic indications

Treatment of patients with locally advanced, non-metastatic prostate cancer, as an alternative to surgical castration.

Treatment of metastatic prostate cancer.

As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.

As neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.

As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression.

Treatment of endometriosis.

Treatment of uterine fibroids prior to surgery or when surgery is not appropriate.

As adjuvant treatment in combination with tamoxifen or an aromatase inhibitor, of endocrine responsive early stage breast cancer in women at high risk of recurrence who are confirmed as pre-menopausal after completion of chemotherapy

Features

Nature and contents of container

A type I, 5 mL capacity glass vial with an elastomer stopper and an aluminium cap containing the powder.

Type I, 3 mL capacity glass ampoule containing 2 mL of the suspension vehicle.

Box containing 1 vial and 1 ampoule with 1 syringe and 2 needles.

Special precautions for storage

Do not store above 25°C. Keep the container in the outer carton.

Shelf life

The product should be used immediately after reconstitution.